Stay updated on Safety of PBCAR20A in NHL/CLL Clinical Trial
Sign up to get notified when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.

Latest updates to the Safety of PBCAR20A in NHL/CLL Clinical Trial page
- Check3 days agoChange DetectedUpdated to revision v3.0.2; v3.0.1 was removed and the 'Back to Top' link was deleted. Overall, this is a minor, non-content-changing update.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has been updated to include new drug information and resources related to B-cell chronic lymphocytic leukemia, while removing previous references to chronic graft versus host disease and other related conditions.SummaryDifference5%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.9%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.6%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference2%
Stay in the know with updates to Safety of PBCAR20A in NHL/CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.